SAVARA INC.

Lobbying client · Pennsylvania · filed 2025 to 2026

Biopharmaceutical company focused on rare respiratory diseases.

$210,000 Reported spend

5 Filings counted

1 Outside firm hired

0 Bills named

Spend is reported income plus in-house expenses across 5 filings. Everything on this page comes from one LDA client record (70499), filed by the registrant listed below.

Who filed for this client 1

LMH STRATEGIC SOLUTIONS $210,000 Outside firm · 5 filings

Spend per registrant: fees an outside firm reported, or the costs the client reported for lobbying in-house. The rows add up to the total above.

Reported by year 2 years

2026 $180,000 3 filings
2025 $30,000 2 filings

Issues lobbied 3

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 4

Executive Office of the President (EOP) 3
Health & Human Services, Dept of (HHS) 3
HOUSE OF REPRESENTATIVES 3
SENATE 3

Recent filings 5 total

Q3 report

LMH STRATEGIC SOLUTIONS

3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $60,000 income · posted Oct 19, 2026

View → Q2 report

LMH STRATEGIC SOLUTIONS

2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $60,000 income · posted Jul 5, 2026

View → Q1 report

LMH STRATEGIC SOLUTIONS

1st Quarter 2026 (Jan 1 - Mar 31) · House · Senate · $60,000 income · posted Apr 17, 2026

View → Q4 report

LMH STRATEGIC SOLUTIONS

4th Quarter 2025 (Oct 1 - Dec 31) · $30,000 income · posted Jan 12, 2026

View → Registration

LMH STRATEGIC SOLUTIONS

4th Quarter 2025 (Oct 1 - Dec 31) · posted Jan 11, 2026

View →

Keep going

Filings through October 19, 2026, the newest posted date on this record. Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.